Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancerDCE-MRI: a review and applications in veterinary oncologySerum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult diseaseIntravenous administration of 9-aminocamptothecin to dogs with lymphoma.Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukaemia.Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002).A feasibility study of low-dose total body irradiation for relapsed canine lymphoma.Efficacy and toxicity of BOPP and LOPP chemotherapy for the treatment of relapsed canine lymphoma.Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.Retrospective--systematic study and quantitative analysis of cellular proliferation and apoptosis in normal, hyperplastic and neoplastic perianal glands in dogs.Peripheral blood abnormalities and bone marrow infiltration in canine large B-cell lymphoma: is there a link?Evaluation of the risks of chemotherapy in dogs with thrombocytopenia.Chronic lymphocytic leukemia transformation into high-grade lymphoma: a description of Richter's syndrome in eight dogs.Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats.Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer.Non-coherent light for photodynamic therapy of superficial tumours in animals.In vitro effects of 2-methoxyestradiol on canine tumour cells.Clastogenic effect of bracken fern (Pteridium aquilinum v. arachnoideum) diet in peripheral lymphocytes of human consumers: preliminary data.Proteomic identification and profiling of canine lymphoma patients.Validation of data collected in the Danish Veterinary Cancer Registry.Vascular-targeted photodynamic therapy (VTP) of a canine-transmissible venereal tumour in a murine model with Pd-bacteriopheophorbide (WST09).β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour.NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imagingGeneration of recombinant antibody fragments that target canine dendritic cells by phage display technology.Canine transmissible venereal tumour: a review.Thymidine kinase assay in canine lymphoma.Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time.Characterization of β-catenin expression in canine osteosarcomaDoxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled study.Radioresistance of cancer stem-like cell derived from canine tumours.Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.Differential expression of microRNAs in bovine papillomavirus type 1 transformed equine cells.Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.Liposomal clodronate treatment for tumour macrophage depletion in dogs with soft-tissue sarcoma.Effectiveness of CO2 laser in an experimental mammary gland adenocarcinoma model.Development of an ELISA to detect circulating anti-asparaginase antibodies in dogs with lymphoid neoplasia treated with Escherichia coli l-asparaginase.Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patternsTumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.
P1433
Q28297938-B16F0AE7-D7DD-45DE-BE0D-B09BB5BA32F8Q28704234-061F633E-D333-44AB-B3EE-CCEC77526BD3Q29400311-5B68CC77-EF99-4D6A-9453-BC8F0166D988Q33384161-40821CD7-F0FD-458C-B7E8-617EBD96EFD5Q33385891-5886BCAB-BDE8-46D0-925C-BE32FD175803Q33386223-66AAD1A5-6CB6-462B-80B2-A5439FD7A4D9Q33386225-943F69E1-2BBA-4A88-B359-34B0C1174D7CQ33386226-9B44618D-5847-4FDD-AD86-286069C0ECD9Q33390397-BD4F454E-ABBA-4FBE-A82D-7B6AAB3BD584Q33403869-6BECEE6E-9529-437B-AE4C-BF026438FE33Q33405954-1118D74C-F829-497A-A483-9F6699F76899Q33421905-FAFFFDE6-971E-4685-9348-312F8E138449Q33426684-8FE61F17-41F0-4C26-AF36-6C902D87ADD8Q33426690-D100440A-3075-49A9-BFB6-BA60C459009EQ33431212-F43E57AE-E84D-4FFC-9C1D-15CE5CFE1DF6Q33431916-F0135B1F-B318-461C-A70F-A6612DF2E6ABQ33432280-8965DDE7-3F76-4039-8C28-257D28356276Q33432283-EAF82609-C29A-4AB9-8335-3013F4342428Q33432286-F3904DB2-AFDC-4CD1-8C31-56FDA5E275B2Q33447697-1D844882-7CC2-4216-8980-9B7674C4B197Q33494944-9674E28A-6016-4CE5-BAAD-85EB4F7184E8Q33503377-C084478D-51EC-4488-83EA-9754CC438529Q33645914-FCDEC862-EBC6-4FCD-9C58-19682243C511Q33706001-61C963E4-1A20-49B6-A810-05DB8068B897Q33994982-F8B97B81-1F07-45CA-AACA-09D7129B3E71Q34037963-1EEF3E35-2B13-49C7-9439-1043647AA999Q34246274-D2F2DFCD-3874-479C-A08D-B8D00C8E2DAAQ34976759-8F3F5522-D396-4536-9E7A-36CECA849B1BQ34997146-73C11174-5FAC-4504-BE46-4F720FA9EB15Q35086217-2E55B416-73F0-47FD-8738-EC70648D4EF3Q35214639-FA19FB88-2FF6-43D0-9D60-CE7B702A26BCQ35580905-0C997561-567E-4FEC-81BC-A24D88DB4732Q35754021-F4EF7223-D58E-47C6-8BD1-32A9EFD1820EQ35978278-B0C2D050-2CBC-48AE-BD44-BDA65AE7327AQ36105408-C9DD9CE5-977D-44DC-BF9E-21157A0353B1Q36133735-B7710E04-556B-4E70-90B7-EC2D647DB5CBQ36332693-56C2F789-0149-48DF-A0C4-A3A6EB3E2862Q36739211-16121F00-3AA7-4810-A0AD-C8B6739EB30AQ36827471-5D2158AC-19A7-4611-A99B-E350220D1E3FQ36827538-8658F8E9-66D1-4D5A-B513-2C7948AB70ED
P1433
description
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
scientific journal
@en
wetenschappelijk tijdschrift van Wiley-Blackwell
@nl
wissenschaftliche Fachzeitschrift
@de
науковий журнал
@uk
مجلة
@ar
name
Veterinary and Comparative Oncology
@ast
Veterinary and Comparative Oncology
@da
Veterinary and Comparative Oncology
@de
Veterinary and Comparative Oncology
@en
Veterinary and Comparative Oncology
@es
Veterinary and Comparative Oncology
@fi
Veterinary and Comparative Oncology
@fr
Veterinary and Comparative Oncology
@it
Veterinary and Comparative Oncology
@nb
Veterinary and Comparative Oncology
@nl
type
label
Veterinary and Comparative Oncology
@ast
Veterinary and Comparative Oncology
@da
Veterinary and Comparative Oncology
@de
Veterinary and Comparative Oncology
@en
Veterinary and Comparative Oncology
@es
Veterinary and Comparative Oncology
@fi
Veterinary and Comparative Oncology
@fr
Veterinary and Comparative Oncology
@it
Veterinary and Comparative Oncology
@nb
Veterinary and Comparative Oncology
@nl
prefLabel
Veterinary and Comparative Oncology
@ast
Veterinary and Comparative Oncology
@da
Veterinary and Comparative Oncology
@de
Veterinary and Comparative Oncology
@en
Veterinary and Comparative Oncology
@es
Veterinary and Comparative Oncology
@fi
Veterinary and Comparative Oncology
@fr
Veterinary and Comparative Oncology
@it
Veterinary and Comparative Oncology
@nb
Veterinary and Comparative Oncology
@nl
P31
P243
P3181
P356
P1055
P1156
16700154702
P1159
P123
P1277
P1476
Veterinary and Comparative Oncology
@en
P236
P243
P3181
P356
10.1111/(ISSN)1476-5829